Impact of Exercise on Myasthenia Gravis: Insights from a Patient-Reported Survey on Activity Patterns and Effects - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Exercise on Myasthenia Gravis: Insights from a Patient-Reported Survey on Activity Patterns and Effects

  • By

  • Stefanie Glaubitz

  • Stefanie Meyer

  • Johanna Loris

  • Rachel Zeng

  • Karsten Kummer

  • Tania Garfias-Veitl

  • Ariana Seraji

  • Lina Hassoun

  • Denise Rohleder

  • Ina Hunger

  • Jana Zschüntzsch

  • December 17, 2025

Share

Clinical Report: Impact of Exercise on Myasthenia Gravis

Overview

This report evaluates the impact of exercise on individuals with myasthenia gravis (MG), highlighting that regular physical activity is safe and beneficial for this population. The study identifies barriers to exercise engagement and emphasizes the need for tailored exercise recommendations.

Background

Myasthenia gravis is a chronic autoimmune disorder that leads to muscle weakness, significantly affecting patients' quality of life. While pharmacological treatments are standard, the role of exercise in managing MG symptoms and improving overall health is gaining recognition. Understanding exercise patterns and barriers in MG patients is crucial for developing effective interventions.

Data Highlights

Remove the statement about no numerical data; include relevant metrics discussed in the source.

Key Findings

  • Exercise is safe for individuals with mild to moderate myasthenia gravis.
  • Current guidelines recommend at least 150 minutes of exercise per week for MG patients.
  • Individuals with MG are generally less physically active compared to healthy controls.
  • Barriers to exercise include post-exertional myalgia, muscular weakness, and motivational challenges.
  • Higher activity levels correlate with lower scores on the Quantitative Myasthenia Gravis Score and MG Activities of Daily Living Scale.

Clinical Implications

Healthcare providers should encourage regular exercise among patients with myasthenia gravis, considering individual capabilities and barriers. Structured activity programs should be developed and monitored using MG-specific outcome measures to enhance patient engagement and health outcomes.

Conclusion

Incorporating exercise into the management of myasthenia gravis can improve patient quality of life and health outcomes. Further research is needed to refine exercise recommendations tailored to this population.

Related Resources & Content

  1. Association of British Neurologists (ABN), 2025 -- Autoimmune Myasthenia Gravis Management Guidelines
  2. Blood Cancer Journal — Factors Influencing Lifestyle Choices in Patients with Multiple Myeloma
  3. Clinical Rheumatology — Utilizing Yoga to Improve Outcomes in Myositis, Muscular Dystrophies, and Various Musculoskeletal Conditions
  4. The ASCO Post — Effect of Exercise on Symptom Burden and Quality of Life in Patients With Metastatic Breast Cancer
  5. Clinical Rheumatology — Exercise that Promotes Health Leads to Positive Mitochondrial Changes in Skeletal Muscle for Patients with Rheumatoid Arthritis
  6. Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)
  7. https://bmcpulmmed.biomedcentral.com/counter/pdf/10.1186/s12890-025-03733-7.pdf
  8. Physical and respiratory training in patients with myasthenia gravis: a systematic review with meta-analysis - PMC

Original Source(s)

Impact of Exercise on Myasthenia Gravis: Insights from a Patient-Reported Survey on Activity Patterns and Effects

  • by Stefanie Glaubitz, Stefanie Meyer, Johanna Loris, Rachel Zeng, Karsten Kummer, Tania Garfias-Veitl, Ariana Seraji, Lina Hassoun, Denise Rohleder, Ina Hunger, Jana Zschüntzsch

  • December 17, 2025

Related Content

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

A Case Study and Literature Review on Type IV Spinal Muscular Atrophy with Gastrocnemius Pseudohypertrophy Due to SMN1 Gene Deletion

Rejo P. Cherian, M.D., Joins Marcus Neuroscience Institute as a Neurologist

Neurologist Rejo P. Cherian, M.D., who specializes in neuromuscular medicine, has joined Marcus Neuroscience Institute, part of Baptist Health Brain & Spine Care

  • by

  • July 9, 2026

  • 2 min